quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:00:00·840d
PRRelease
ReWalk Robotics Ltd. logo

ReWalk Robotics CEO Issues Year-End 2023 Open Letter to Shareholders and Provides 2024 Commercial and Operational Priorities

RWLK· ReWalk Robotics Ltd.
Health Care
Original source

Companies

  • RWLK
    ReWalk Robotics Ltd.
    Health Care

Related

  • PR762d
    VA STAND Act introduced in the United States Senate
  • PR771d
    Lifeward Announces Reverse Share Split
  • PR776d
    ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy
  • PR783d
    Lifeward announces the Centers for Medicare & Medicaid Services ("CMS") is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be considered
  • PR786d
    Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results
  • PR793d
    Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024
  • SEC814d
    ReWalk Robotics Ltd. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • PR815d
    ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022